Amphastar Pharmaceuticals Quick Ratio 2012-2026 | AMPH
Historical quick ratio values for Amphastar Pharmaceuticals (AMPH) over the last 10 years.
| Amphastar Pharmaceuticals Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2026-03-31 | $0.46B | $0.16B | 2.82 |
| 2025-12-31 | $0.46B | $0.16B | 2.90 |
| 2025-09-30 | $0.45B | $0.21B | 2.21 |
| 2025-06-30 | $0.39B | $0.18B | 2.21 |
| 2025-03-31 | $0.40B | $0.20B | 2.02 |
| 2024-12-31 | $0.38B | $0.17B | 2.19 |
| 2024-09-30 | $0.42B | $0.16B | 2.61 |
| 2024-06-30 | $0.36B | $0.14B | 2.63 |
| 2024-03-31 | $0.44B | $0.26B | 1.72 |
| 2023-12-31 | $0.38B | $0.23B | 1.70 |
| 2023-09-30 | $0.43B | $0.26B | 1.68 |
| 2023-06-30 | $0.28B | $0.25B | 1.11 |
| 2023-03-31 | $0.30B | $0.11B | 2.88 |
| 2022-12-31 | $0.28B | $0.10B | 2.90 |
| 2022-09-30 | $0.28B | $0.10B | 2.75 |
| 2022-06-30 | $0.28B | $0.10B | 2.69 |
| 2022-03-31 | $0.27B | $0.11B | 2.35 |
| 2021-12-31 | $0.23B | $0.10B | 2.17 |
| 2021-09-30 | $0.20B | $0.10B | 2.08 |
| 2021-06-30 | $0.21B | $0.13B | 1.71 |
| 2021-03-31 | $0.20B | $0.13B | 1.60 |
| 2020-12-31 | $0.18B | $0.11B | 1.63 |
| 2020-09-30 | $0.17B | $0.10B | 1.73 |
| 2020-06-30 | $0.16B | $0.09B | 1.74 |
| 2020-03-31 | $0.14B | $0.08B | 1.67 |
| 2019-12-31 | $0.15B | $0.09B | 1.61 |
| 2019-09-30 | $0.16B | $0.09B | 1.84 |
| 2019-06-30 | $0.19B | $0.10B | 1.83 |
| 2019-03-31 | $0.15B | $0.11B | 1.35 |
| 2018-12-31 | $0.15B | $0.11B | 1.41 |
| 2018-09-30 | $0.13B | $0.10B | 1.34 |
| 2018-06-30 | $0.11B | $0.09B | 1.24 |
| 2018-03-31 | $0.11B | $0.07B | 1.53 |
| 2017-12-31 | $0.12B | $0.07B | 1.85 |
| 2017-09-30 | $0.11B | $0.06B | 1.86 |
| 2017-06-30 | $0.12B | $0.06B | 1.87 |
| 2017-03-31 | $0.11B | $0.07B | 1.56 |
| 2016-12-31 | $0.10B | $0.06B | 1.72 |
| 2016-09-30 | $0.10B | $0.06B | 1.64 |
| 2016-06-30 | $0.09B | $0.07B | 1.42 |
| 2016-03-31 | $0.09B | $0.07B | 1.41 |
| 2015-12-31 | $0.11B | $0.06B | 1.76 |
| 2015-09-30 | $0.13B | $0.07B | 1.79 |
| 2015-06-30 | $0.12B | $0.07B | 1.78 |
| 2015-03-31 | $0.12B | $0.07B | 1.63 |
| 2014-12-31 | $0.12B | $0.06B | 1.85 |
| 2014-09-30 | $0.13B | $0.06B | 2.02 |
| 2014-06-30 | $0.11B | $0.06B | 1.92 |
| 2014-03-31 | $0.10B | $0.07B | 1.35 |
| 2013-12-31 | $0.10B | $0.07B | 1.58 |
| 2013-09-30 | $0.00B | 0.00 | |
| 2013-06-30 | $0.00B | 0.00 | |
| 2013-03-31 | $0.00B | 0.00 | |
| 2012-12-31 | $0.11B | $0.06B | 1.90 |
| 2012-09-30 | $0.00B | 0.00 | |
| 2012-06-30 | $0.00B | 0.00 | |
| 2012-03-31 | $0.00B | 0.00 | |
| 2011-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.924B | $0.720B |
| Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |